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sions for Medicare beneficiaries originate in the emergency
department (ED). Research suggests that some of these pa-
tients’ needs may be better met through home-based care
options after evaluation and treatment in the ED. Objective:
We sought to estimate Medicare cost savings resulting from
using the Home Health benefit to provide treatment, when
appropriate, as an alternative to inpatient admission from
the ED. Methods: This is a prospective study of patients
admitted from the ED. A survey tool was used to query
both emergency physicians (EPs) and patient medical re-
cord data to identify potential candidates and treatments
for home-based care alternatives. Patient preferences were
also surveyed. Cost savings were estimated by developing a
model of Medicare Home Health to serve as a counterpart
to the actual hospital-based care. Results: EPs identified
40% of the admitted patients included in the study as candi-
dates for home-based care. The top three major diagnostic
categories included diseases and disorders of the respiratory
system, digestive system, and skin. Services included intra-
venous hydration, intravenous antibiotics, and laboratory
testing. The average estimated cost savings between the
Medicare inpatient reimbursement and the Home Health
counterpart was approximately $4000. Of the candidate pa-
tients surveyed, 79% indicated a preference for home-based
care after treatment in the ED. Conclusions: SomeMedicaret available from the authors.
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643beneficiaries could be referred to Home Health from the ED
with a concomitant reduction in Medicare expenditures.
Additional studies are needed to compare outcomes, develop
the logistical pathways, and analyze infrastructure costs and
incentives to enable Medicare Home Health options from
the ED.  2016 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Inpatient medical care accounts for approximately 29%
of total medical expenditures in the United States, and
it is important to consider the emergency department
(ED) and its emerging role as a gateway to inpatient hos-
pital care, especially as it pertains to Medicare benefi-
ciaries (1,2). Specifically, almost 70% of admissions for
Medicare beneficiaries originate in the ED (1,3). Most
health systems do not presently support easy access to
ED-based outpatient treatment options that could reduce
inpatient admissions (4). Of the 19.3 million ED visits
that resulted in hospitalization in 2011, 52% werene 2016;
644 C. Crowley et al.Medicare beneficiaries, some of whom faced significant
risks for delirium, nosocomial infections, and falls
(3,4). The development of health service innovations
that provide home-based alternatives after treatment in
the ED may reduce the incidence of these hospital-
based complications while simultaneously allowing pa-
tients to be cared for in the comfort and safety of their
own homes. A prospective survey-based study was con-
ducted to understand the cost implications associated
with the development of such home-based care options
from the ED.
IMPORTANCE
In 2015, the Department of Health and Human
Services (HHS) announced explicit goals pertaining to
alternative payment models and value-based payments
(5). Many of these payment models build on traditional
Medicare fee-for-service benefits while incentivizing pro-
viders to consider resource utilization levels and to assume
financial risk to develop health service innovations that
achieve high quality care better matched to the needs of se-
niors.
The Medicare Home Health benefit presently covers
certain home-based skilled medical services carried out
in accordance with a plan of care signed by a supervising
physician. The physician must certify that the beneficiary
has both a specific medical need and is homebound. How-
ever, compared to the relative ease of recommending
inpatient admission, ordering Home Health from the
ED may be more complex and time-consuming. Physi-
cian hand-off from the emergency physician (EP) to the
patient’s primary care physician (or other medical super-
visory care) may also be difficult. Finally, Home Health
agencies may not currently meet the faster response times
needed to address patient needs after ED treatment.
Because providers may need to assume financial risk
and invest in infrastructure to overcome these types of
challenges, it is critical to first understand the cost impli-
cations of this alternative treatment approach, beginning
from the perspective of Medicare expenditures.
OBJECTIVE
The objective of this study was to understand both patient
and clinical acceptance and cost implications associated
with using the Home Health Medicare benefit as an alter-
native to inpatient admission after ED treatment. To that
end, the study first characterized patient acceptance and
patient care pathways (treatments) identified by EPs as
being appropriate for home-based care referral. The study
then used these characterizations as a basis to estimate
hypothetical Home Health costs and savings.MATERIALS AND METHODS
Study Design and Setting
A prospective study was conducted that comprised of a
survey of both attending EPs and patients with initial or-
ders for admission to medical units from two EDs. The
EDs used in the study were part of an academic health sys-
tem with two hospitals and a combined annual census of
75,000 patients. One hospital was an urban, academic
teaching hospital (a level 1 trauma center) and the other
was a suburban community hospital. Patients included
English-speaking adults$18 years of age who had no or-
ders for telemetry. Patient recruitment took place intermit-
tently from September 2014 to March 2014 to generate a
convenience sample. For each recruited patient, physician
recruitment was limited to the EP attending (i.e., residents
and interns were excluded). This study was approved by
the teaching hospital’s institutional review board.DATA COLLECTION AND PROCESSING
Measures and procedures
A first survey tool was used to query patients with initial
orders to be admitted to the hospital from the ED in order
to determine their potential preference for a home-base
alternative care, if it were to be made available. A second
survey tool was used to query the EP attending to deter-
mine whether the patient could be a candidate for
home-based care, also if it were to be made available as
an alternative to inpatient admission. For each candidate,
medical record data were queried to characterize both the
ED and inpatient episodes of care. The study was not
limited to Medicare beneficiaries.
Medicare cost savings were estimated by calcu-
lating prospective payments for both actual inpatient
hospital costs and hypothetical alternatives of Home
Health. In the case of inpatient care, the prospective
payments were determined by the Medicare Services
Diagnostic Related Group (MS-DRG) designated in
the health record. These identified MS-DRGs were
also mapped into the corresponding major diagnostic
categories (MDCs).
To model the Home Health alternative, prospective
payments were estimated based on designated Home
Health–related groups (HHRGs). Specifically, medical
skilled care services provided during the inpatient
episode of care were identified using both the queried
ED and inpatient records. Functional status and service
needs were also estimated. These assessments (i.e., med-
ical, functional, and service) were then used to complete
pertinent line items in the Medicare Outcomes and
Assessment Information Set. Medicare Outcomes and
Pilot to Estimate Cost Savings for Medicare Home Health 645Assessment Information Set data were then used to deter-
mine estimated county-wide HHRG payments for equiv-
alent early-episode home health services.
It is important to note that the HHRG payment does
not cover all nonphysician services that may have been
provided in the hospital. In particular, while costs for
medications, laboratory, imaging, and durable medical
equipment are all folded into the MS-DRG, they are not
included in HHRG payments, so additional charges
must be considered before performing the MS-DRG/
HHRG comparison. To include these additional charges
in the overall comparison, adjusted HHRG payments
were derived using the standard U.S.-wide Medicare
5% dataset for each of the HHRGs to obtain an adjust-
ment multiplier reflective of average additional costs
for medications, laboratory, and imaging services. These
adjusted HHRGs were then compared to the county-wide
average MS-DRG payments for each patient to arrive at
the estimated cost savings.
RESULTS
Characteristics of Study Subjects
The EPs surveyed in the study identified 25 of 63 patients
with preliminary orders (40%) as potential candidates for
Home Health instead of admission, had the Home Health
option been available. Of these 25 patients selected, four
patients either declined admission or were subsequently
discharged despite having preliminary admission orders.
No additional data were available pertaining to these four
discharged patients, so they were excluded from subse-
quent analysis. Two other patients were excluded from
subsequent analyses because no MS-DRG was desig-
nated at the time of review.
Main Results
Of the 19 patients designated by the surveyed attending
EPs to be included in the analysis, 12 MS-DRGs map-
ped to the same set of three MDCs: MDC 4, ‘‘Diseases
and Disorders (DDs) of the Respiratory System’’ (2
white males, 2 white females; average age 57 years);
MDC 6, ‘‘DDs of the Digestive System’’ (1 Hispanic fe-
male, 1 Hispanic male, 1 African-American male, 1
white male, 1 multiracial male; average age, 38 years);
and MDC9, ‘‘DDs of the Skin, Subcutaneous Tissue and
Breast’’ (1 white male, 2 white females; average age
55 years). EP-designated services needed to enable
home-based care included intravenous antibiotic ther-
apy, intravenous hydration, and laboratory analysis.
For the patients enrolled in the study, the difference be-tween the MS-DRG reimbursement and the adjusted
HHRG payments ranged from $1828 to $9857, with a
median difference of $2957 and an interquartile range
of $2692. The average difference was $4144. Of the
19 patients included in the analysis, 15 indicated that
they would have preferred to have their health care at
home.
DISCUSSION
Currently, most provider systems offer only three options
after ED treatment: admit, discharge, or observe. Howev-
er, this study suggests that 1) patients and providers
would be accepting of home-based treatment options
and 2) such options could be provided at lower levels of
Medicare expenditure.
Limitations
The cost implications analyzed for the present study
were limited to estimates of Medicare expenditures—
provider investments and incentives to develop infra-
structure necessary to realize these savings were not
considered. In addition, the patient enrollment for the
study was not limited to Medicare beneficiaries, so the
study does not provide a basis for inferring actual
numbers or percentages of Medicare beneficiaries.
Because the study did not involve an actual home-
based treatment arm, outcomes are not available and
Medicare expenditures associated with possible addi-
tional outpatient costs (e.g., office visits or return ED
visits) were not reflected in the estimates. There is a
risk that the intermittency of patient recruitment over
the 7-month time frame could have introduced a conve-
nience bias into the patient pool and their appropriate-
ness for home-based options.
There are limitations to the methodology of
comparing MS-DRG and HHRG payments to estimate
care cost savings associated with ED-based referrals to
Home Health as an alternative to inpatient hospital
care. Specifically, the inpatient MS-DRG is mainly diag-
nosis and severity-based, while the comparison HHRG
payment is based more on service needs. The MS-
DRGs could be slightly underestimated because they do
not include common adjustments, such as graduate med-
ical education, disproportionate share hospital status, and
the like. Other limitations of the comparison include the
fact the HHRG-estimated payments were constructed
based on the total care received in the inpatient counter-
part, including the ED-based component of care. For
the Medicare beneficiaries, ED-based care is combined
into the inpatient MS-DRG payment for those patients
646 C. Crowley et al.admitted from the ED. For a patient receiving Home
Health after ED treatment, the ED-based portion is sepa-
rated, so there would be an additional ED facility fee.
However, the actual HHRG payment would then be lower
than the estimates used in the study, because the actual
HHRG would not include the ED portion of care. Differ-
ences in physician fees were not considered, nor were
actual costs associated with providing new infrastructure
or process-related changes needed to support the Home
Health option from the ED.
CONCLUSIONS
This study suggests that EPs would designate certain pa-
tient cohorts for Home Health as an alternative to admis-
sion after ED treatment and that the concomitant
Medicare cost savings would be substantial for this alter-
native. The survey supports follow-on studies involving
the actual provision of home-based care from the ED,
both to compare outcomes and to provide a basis for anal-
ysis of incentives and investment needed to develop logis-
tics, technology, and infrastructure for ED-based home
care referral options.Acknowledgments—Supported by a research contract from the
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1. Why is this topic important?
Emerging value-based payment models are expected to
incentivize provider systems to develop more home-based
care alternatives to hospital-based care, including care
originating in the emergency department (ED). Providers
may need to assume financial risk to develop these alter-
natives, and it is important to first understand the cost im-
plications, especially from the perspective of Medicare
expenditures.
2. What does this study attempt to show?
The study attempts to estimate the cost savings associ-
ated with usingMedicare HomeHealth as an alternative to
inpatient admission after ED treatment. The study also at-
tempts to characterize patient acceptance and treatments
identified by emergency physicians as being appropriate
for home-based care referral.
3. What are the key findings?
For the patients included in the study analysis, the
average reimbursement difference between the hospital
and Home Health alternative was estimated to be $4144.
Emergency physician–designated services included intra-
venous antibiotic therapy, intravenous hydration, and lab-
oratory analysis. Of the 19 patients included in the
analysis, 15 indicated that they would have preferred to
have their health care at home.
4. How is patient care impacted?
There is potential to reduce the incidence of ‘‘default’’
inpatient admissions originating from the ED, which may
in turn reduce the incidence of hospital-based complica-
tions while simultaneously allowing patients to be cared
for in the comfort and safety of their own homes.
